The who classification of pulmonary hypertension: A case-based imaging compendium

John J. Ryan, Thenappan Thenappan, Nancy Luo, Thanh Ha, Amit R. Patel, Stuart Rich, Stephen L. Archer

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pulmonary hypertension (PH) is defined as a resting mean pulmonary artery pressure greater than 25 mmHg. The World Health Organization (WHO) classifies PH into five categories. The WHO nomenclature assumes shared histology and pathophysiology within categories and implies category-specific treatment. Imaging of the heart and pulmonary vasculature is critical to assigning a patient’s PH syndrome to the correct WHO category and is also important in predicting outcomes. Imaging studies often reveal that the etiology of PH in a patient reflects contributions from several categories. Overlap between Categories 2 and 3 (left heart disease and lung disease) is particularly common, reflecting shared risk factors. Correct classification of PH patients requires the combination of standard imaging (chest roentgenograms, ventilation-perfusion scans, echocardiography, and the 12-lead electrocardiogram) and advanced imaging (computed tomography, cardiac magnetic resonance imaging, and positron emission tomography). Despite the value of imaging, cardiac catheterization remains the gold standard for quantification of hemodynamics and is required before initiation of PH-specific therapy. These cases illustrate the use of imaging in classifying patients into WHO PH Categories 1-5.

Original languageEnglish (US)
Pages (from-to)107-121
Number of pages15
JournalPulmonary Circulation
Volume2
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Cardiac Catheterization
Terminology
Positron-Emission Tomography
Pulmonary Artery
Lung Diseases
Ventilation
Echocardiography
Heart Diseases
Histology
Electrocardiography
Thorax
Perfusion
Hemodynamics
Tomography
Magnetic Resonance Imaging
Pressure
Lung
Therapeutics

Keywords

  • CREST
  • Eisenmenger’s syndrome
  • Late gadolinium enhancement
  • Pulmonary artery acceleration time
  • Pulmonary capillary hemangiomatosis
  • Pulmonary veno-occlusive disease
  • Right ventricular hypertrophy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Ryan, J. J., Thenappan, T., Luo, N., Ha, T., Patel, A. R., Rich, S., & Archer, S. L. (2012). The who classification of pulmonary hypertension: A case-based imaging compendium. Pulmonary Circulation, 2(1), 107-121. https://doi.org/10.4103/2045-8932.94843

The who classification of pulmonary hypertension : A case-based imaging compendium. / Ryan, John J.; Thenappan, Thenappan; Luo, Nancy; Ha, Thanh; Patel, Amit R.; Rich, Stuart; Archer, Stephen L.

In: Pulmonary Circulation, Vol. 2, No. 1, 01.2012, p. 107-121.

Research output: Contribution to journalArticle

Ryan, JJ, Thenappan, T, Luo, N, Ha, T, Patel, AR, Rich, S & Archer, SL 2012, 'The who classification of pulmonary hypertension: A case-based imaging compendium', Pulmonary Circulation, vol. 2, no. 1, pp. 107-121. https://doi.org/10.4103/2045-8932.94843
Ryan, John J. ; Thenappan, Thenappan ; Luo, Nancy ; Ha, Thanh ; Patel, Amit R. ; Rich, Stuart ; Archer, Stephen L. / The who classification of pulmonary hypertension : A case-based imaging compendium. In: Pulmonary Circulation. 2012 ; Vol. 2, No. 1. pp. 107-121.
@article{c6577a440d2f4bcb832837fd73fc4151,
title = "The who classification of pulmonary hypertension: A case-based imaging compendium",
abstract = "Pulmonary hypertension (PH) is defined as a resting mean pulmonary artery pressure greater than 25 mmHg. The World Health Organization (WHO) classifies PH into five categories. The WHO nomenclature assumes shared histology and pathophysiology within categories and implies category-specific treatment. Imaging of the heart and pulmonary vasculature is critical to assigning a patient’s PH syndrome to the correct WHO category and is also important in predicting outcomes. Imaging studies often reveal that the etiology of PH in a patient reflects contributions from several categories. Overlap between Categories 2 and 3 (left heart disease and lung disease) is particularly common, reflecting shared risk factors. Correct classification of PH patients requires the combination of standard imaging (chest roentgenograms, ventilation-perfusion scans, echocardiography, and the 12-lead electrocardiogram) and advanced imaging (computed tomography, cardiac magnetic resonance imaging, and positron emission tomography). Despite the value of imaging, cardiac catheterization remains the gold standard for quantification of hemodynamics and is required before initiation of PH-specific therapy. These cases illustrate the use of imaging in classifying patients into WHO PH Categories 1-5.",
keywords = "CREST, Eisenmenger’s syndrome, Late gadolinium enhancement, Pulmonary artery acceleration time, Pulmonary capillary hemangiomatosis, Pulmonary veno-occlusive disease, Right ventricular hypertrophy",
author = "Ryan, {John J.} and Thenappan Thenappan and Nancy Luo and Thanh Ha and Patel, {Amit R.} and Stuart Rich and Archer, {Stephen L.}",
year = "2012",
month = "1",
doi = "10.4103/2045-8932.94843",
language = "English (US)",
volume = "2",
pages = "107--121",
journal = "Pulmonary Circulation",
issn = "2045-8932",
publisher = "University of Chicago Press",
number = "1",

}

TY - JOUR

T1 - The who classification of pulmonary hypertension

T2 - A case-based imaging compendium

AU - Ryan, John J.

AU - Thenappan, Thenappan

AU - Luo, Nancy

AU - Ha, Thanh

AU - Patel, Amit R.

AU - Rich, Stuart

AU - Archer, Stephen L.

PY - 2012/1

Y1 - 2012/1

N2 - Pulmonary hypertension (PH) is defined as a resting mean pulmonary artery pressure greater than 25 mmHg. The World Health Organization (WHO) classifies PH into five categories. The WHO nomenclature assumes shared histology and pathophysiology within categories and implies category-specific treatment. Imaging of the heart and pulmonary vasculature is critical to assigning a patient’s PH syndrome to the correct WHO category and is also important in predicting outcomes. Imaging studies often reveal that the etiology of PH in a patient reflects contributions from several categories. Overlap between Categories 2 and 3 (left heart disease and lung disease) is particularly common, reflecting shared risk factors. Correct classification of PH patients requires the combination of standard imaging (chest roentgenograms, ventilation-perfusion scans, echocardiography, and the 12-lead electrocardiogram) and advanced imaging (computed tomography, cardiac magnetic resonance imaging, and positron emission tomography). Despite the value of imaging, cardiac catheterization remains the gold standard for quantification of hemodynamics and is required before initiation of PH-specific therapy. These cases illustrate the use of imaging in classifying patients into WHO PH Categories 1-5.

AB - Pulmonary hypertension (PH) is defined as a resting mean pulmonary artery pressure greater than 25 mmHg. The World Health Organization (WHO) classifies PH into five categories. The WHO nomenclature assumes shared histology and pathophysiology within categories and implies category-specific treatment. Imaging of the heart and pulmonary vasculature is critical to assigning a patient’s PH syndrome to the correct WHO category and is also important in predicting outcomes. Imaging studies often reveal that the etiology of PH in a patient reflects contributions from several categories. Overlap between Categories 2 and 3 (left heart disease and lung disease) is particularly common, reflecting shared risk factors. Correct classification of PH patients requires the combination of standard imaging (chest roentgenograms, ventilation-perfusion scans, echocardiography, and the 12-lead electrocardiogram) and advanced imaging (computed tomography, cardiac magnetic resonance imaging, and positron emission tomography). Despite the value of imaging, cardiac catheterization remains the gold standard for quantification of hemodynamics and is required before initiation of PH-specific therapy. These cases illustrate the use of imaging in classifying patients into WHO PH Categories 1-5.

KW - CREST

KW - Eisenmenger’s syndrome

KW - Late gadolinium enhancement

KW - Pulmonary artery acceleration time

KW - Pulmonary capillary hemangiomatosis

KW - Pulmonary veno-occlusive disease

KW - Right ventricular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=84867592712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867592712&partnerID=8YFLogxK

U2 - 10.4103/2045-8932.94843

DO - 10.4103/2045-8932.94843

M3 - Article

AN - SCOPUS:84867592712

VL - 2

SP - 107

EP - 121

JO - Pulmonary Circulation

JF - Pulmonary Circulation

SN - 2045-8932

IS - 1

ER -